AI
Sunday, December 25, 2011 9:31:15 AM
Baxter Facts In Brief {No small potatoes 
}
Corporate Headquarters
Deerfield, Illinois, USA
Established
1931
Employees
Approximately 48,000 worldwide
Businesses
• BioScience
• Medical Products
2010 Sales
$12.8 billion
2010 Sales by Region {See graph via link - P. 16} (millions)including facilities in Austria, Belgium, Japan and the United States, as well as in conjunction with select R&D partners. Baxter had 14 programs in Phase III clinical trials in 2010.
2010 R&D Investment
$915 million
Manufacturing
Baxter manufactures products in 27 countries: Australia, Austria,
Belgium, Brazil, Canada, Chile, China, Colombia, Costa Rica, the
Czech Republic, Germany, India, Ireland, Italy, Japan, Malta, Mexico, the Philippines, Poland, Saudi Arabia, Singapore, Spain, Switzerland, Tunisia, Turkey, the United Kingdom and the United States, including Puerto Rico.
Operations
Baxter has operations (including offices and manufacturing/
distribution facilities) in 62 countries. The company conducts
business in more than 100 countries.
Sustainability
Baxter has been recognized by many sustainability-related
organizations. In 2010, Baxter was named:
• to the Dow Jones Sustainability Index for the 12th straight year, and the Medical Products leader for the ninth time
• one of the Global 100 Most Sustainable Corporations
by Corporate Knights Inc.
• to Fortune magazine’s list of the World’s Most Admired Companies
• first in the healthcare category of Newsweek magazine’s
“Green Rankings” of the 500 largest U.S. companies,
and ranked 15th overall
• to the 100 Best Corporate Citizens list by
Corporate Responsibility magazine
http://www.baxter.com/downloads/press_room/corporate_overview/2011_baxter_corporate_brochure.pdf
} Corporate Headquarters
Deerfield, Illinois, USA
Established
1931
Employees
Approximately 48,000 worldwide
Businesses
• BioScience
• Medical Products
2010 Sales
$12.8 billion
2010 Sales by Region {See graph via link - P. 16} (millions)including facilities in Austria, Belgium, Japan and the United States, as well as in conjunction with select R&D partners. Baxter had 14 programs in Phase III clinical trials in 2010.
2010 R&D Investment
$915 million
Manufacturing
Baxter manufactures products in 27 countries: Australia, Austria,
Belgium, Brazil, Canada, Chile, China, Colombia, Costa Rica, the
Czech Republic, Germany, India, Ireland, Italy, Japan, Malta, Mexico, the Philippines, Poland, Saudi Arabia, Singapore, Spain, Switzerland, Tunisia, Turkey, the United Kingdom and the United States, including Puerto Rico.
Operations
Baxter has operations (including offices and manufacturing/
distribution facilities) in 62 countries. The company conducts
business in more than 100 countries.
Sustainability
Baxter has been recognized by many sustainability-related
organizations. In 2010, Baxter was named:
• to the Dow Jones Sustainability Index for the 12th straight year, and the Medical Products leader for the ninth time
• one of the Global 100 Most Sustainable Corporations
by Corporate Knights Inc.
• to Fortune magazine’s list of the World’s Most Admired Companies
• first in the healthcare category of Newsweek magazine’s
“Green Rankings” of the 500 largest U.S. companies,
and ranked 15th overall
• to the 100 Best Corporate Citizens list by
Corporate Responsibility magazine
http://www.baxter.com/downloads/press_room/corporate_overview/2011_baxter_corporate_brochure.pdf
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
